Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets ![]() |
---|---|---|---|---|
Capital Group Central Cash Fund | Short Term | 7,084,876 | $708,487,568.00 | 6.7% |
U.S. Treasury 3.875% 6/30/2030 | Fixed Income | 322,555,000 | $323,802,481.00 | 3.06% |
U.S. Treasury 4.25% 5/15/2035 | Fixed Income | 172,411,000 | $172,640,289.00 | 1.63% |
New Economy Assets Phase 1 Issuer, LLC, Series 2021-1, Class A1, 1.91% 10/20/2061 | Fixed Income | 85,198,000 | $80,281,735.00 | 0.76% |
Chubb INA Holdings, LLC 5.00% 3/15/2034 | Fixed Income | 77,669,000 | $79,169,876.00 | 0.75% |
Bristol-Myers Squibb Co. 5.20% 2/22/2034 | Fixed Income | 76,118,000 | $77,986,925.00 | 0.74% |
U.S. Treasury 5% 5/15/2045 | Fixed Income | 76,363,000 | $78,433,315.00 | 0.74% |
Pacific Gas and Electric Co. 2.50% 2/1/2031 | Fixed Income | 86,139,000 | $74,818,354.00 | 0.71% |
Cisco Systems, Inc. 5.05% 2/26/2034 | Fixed Income | 69,323,000 | $70,985,712.00 | 0.67% |
Takeda U.S. Financing, Inc. 5.20% 7/7/2035 | Fixed Income | 69,251,000 | $69,286,457.00 | 0.65% |
AbbVie, Inc. 5.05% 3/15/2034 | Fixed Income | 66,997,000 | $68,239,258.00 | 0.64% |
Synopsys, Inc. 5.15% 4/1/2035 | Fixed Income | 66,979,000 | $67,538,208.00 | 0.64% |
U.S. Treasury 3.875% 6/15/2028 | Fixed Income | 66,823,000 | $67,175,358.00 | 0.63% |
Oracle Corp. 5.50% 8/3/2035 | Fixed Income | 64,456,000 | $65,912,963.00 | 0.62% |
Pfizer Investment Enterprises Pte., Ltd. 5.30% 5/19/2053 | Fixed Income | 65,138,000 | $61,539,386.00 | 0.58% |